Where the power of nature meets the logic of science for the betterment of health.
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property. We then utilize our in-house chemistry, regulatory and safety consulting business units to commercialize the ingredients. Our ingredient portfolio is backed with clinical and scientific research, as well as extensive patent protection. Our portfolio of ingredient technologies includes NIAGEN® nicotinamide riboside; pTeroPure® pterostilbene and; PURENERGY®, a caffeine-pTeroPure® co-crystal. To learn more about ChromaDex, please visit www.chromadex.com.
Andrew Johnson, Director of Investor Relations